Alsius (ALUS) Announces FDA Clearance to Market Solex(TM) Heat Exchange Catheter
More News related to ALUS
- Alsius Corporation Completes Sale of Assets to ZOLL Medical Corporation
- ZOLL Medical Completes Purchase of Assets from Alsius Corporation
- ALSIUS (ALUS) Misses Q3 EPS by 2c
- Alsius (ALUS) Announces FDA Clearance to Market Solex(TM) Heat Exchange Catheter
- Ramius Capital Discloses 5.2% Stake in Alsius (ALUS)
Alsius Corporation (Nasdaq: ALUS) today announced that the U.S. FDA has granted the company 510(k) clearance to market the Solex(TM) heat exchange catheter.
Solex is a new catheter, developed by Alsius, that advances the company's leadership in intravascular patient temperature management. Solex offers clinicians maximum heat exchange power from a standard neck insertion, while providing triple lumen central venous access.
Alsius Corporation develops, manufactures, markets, and sells catheter-based intravascular temperature management products to control patient temperature in hospital critical care settings.
Related Categories
FDAStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
